Corbus Pharmaceuticals Holdings (CRBP) Profit After Tax (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Profit After Tax (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -32.16% |
| Jun 30, 2025 | -4.03% |
| Mar 31, 2025 | -78.15% |
| Dec 31, 2024 | 30.86% |
| Sep 30, 2024 | -37.87% |
| Jun 30, 2024 | -44.91% |
| Mar 31, 2024 | 14.00% |
| Dec 31, 2023 | 20.20% |
| Sep 30, 2023 | -14.45% |
| Jun 30, 2023 | 50.50% |
| Mar 31, 2023 | -63.11% |
| Dec 31, 2022 | -22.66% |
| Sep 30, 2022 | 33.06% |
| Jun 30, 2022 | -38.81% |
| Mar 31, 2022 | 6.98% |
| Dec 31, 2021 | -371.51% |
| Sep 30, 2021 | 87.30% |
| Jun 30, 2021 | -6.68% |
| Mar 31, 2021 | -86.55% |
| Dec 31, 2020 | 75.32% |